Association of Genetic Polymorphisms of Anti-Müllerian Hormone (AMH) and Its Type II Receptor with Ovarian Hyperstimulation Syndrome

Type Ii

Abstract #852 A Case of FSH-Secreting Pituitary Adenoma Leading to Spontaneous Ovarian Hyperstimulation Syndrome

Endocrine Practice ◽

10.1016/s1530-891x(20)47338-0 ◽

2018 ◽

Vol 24 ◽

pp. 200

Author(s):

Adva Eisenberg ◽

Jennifer Mersereau ◽

Lauren Gratian

Keyword(s):

Pituitary Adenoma ◽

Ovarian Hyperstimulation Syndrome

10.1017/cbo9780511547294 ◽

2001 ◽

Author(s):

Botros Rizk

Keyword(s):

Thrombosis Associated with Ovarian Hyperstimulation Syndrome in a Carrier of the Factor V Leiden Mutation

Thrombosis and Haemostasis ◽

10.1055/s-0038-1650569 ◽

1996 ◽

Vol 76 (02) ◽

pp. 275-277 ◽

Cited By ~ 3

Author(s):

Sylvie Hollemaert ◽

Jean-Claude Wautrecht ◽

Paul Capel ◽

Marc J Abramowicz ◽

Yvon Englert ◽

...

Keyword(s):

Factor V Leiden ◽

Factor V ◽

Factor V Leiden Mutation

Evaluation of functional gene polymorphisms in the FSH receptor of patients with Ovarian Hyperstimulation Syndrome (OHSS)

Geburtshilfe und Frauenheilkunde ◽

10.1055/s-2006-952215 ◽

2006 ◽

Vol 66 (S 01) ◽

Author(s):

H Binder ◽

I Hager ◽

S Cupisti ◽

PL Strissel ◽

MW Beckmann ◽

...

Keyword(s):

Gene Polymorphisms ◽

Functional Gene ◽

Fsh Receptor ◽

A comparison of Ovarian Hyperstimulation Syndrome (OHSS) parameters following different triggers of oocyte maturation during IVF Treatment

Endocrine Abstracts ◽

10.1530/endoabs.50.p352 ◽

2017 ◽

Author(s):

SA Clarke ◽

A Abbara ◽

R Islam ◽

L Jeffers ◽

G Christopoulos ◽

...

Keyword(s):

Oocyte Maturation ◽

Gonadotroph pituitary macroadenoma inducing ovarian hyperstimulation syndrome

Endocrine Abstracts ◽

10.1530/endoabs.56.p801 ◽

2018 ◽

Author(s):

Blertina Dyrmishi ◽

Taulant Olldashi ◽

Entela Puca ◽

Ema Lumi ◽

Dorina Ylli

Keyword(s):

Pituitary Macroadenoma

Do not dismiss the long downregulation protocol for women at risk of ovarian hyperstimulation syndrome (OHSS)

10.26226/morressier.573c1514d462b80296c98ca9 ◽

2016 ◽

Author(s):

Athanasios Papathanasiou

Keyword(s):

At Risk ◽

Nursing protocol for the risk identification and prevention of Ovarian Hyperstimulation Syndrome (OHSS) in patients undergoing IVF treatment

10.26226/morressier.5912d9ebd462b80292386365 ◽

2017 ◽

Author(s):

Tatianne Figueiredo

Keyword(s):

Risk Identification ◽

Faculty Opinions recommendation of Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13991957.15448065 ◽

2012 ◽

Author(s):

Björn Heindryckx ◽

Frauke Vanden Meerschaut

Keyword(s):

Oocyte Maturation ◽

Gnrh Agonist ◽

Low Dose ◽

Pregnancy Rates ◽

Low Dose Hcg

Faculty Opinions recommendation of Prevention of ovarian hyperstimulation syndrome in GnRH agonist IVF cycles in moderate risk patients: randomized study comparing hydroxyethyl starch versus cabergoline and hydroxyethyl starch.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718072126.793488021 ◽

2013 ◽

Author(s):

Raoul Orvieto

Keyword(s):

Hydroxyethyl Starch ◽

Gnrh Agonist ◽

Randomized Study ◽

Moderate Risk ◽

Risk Patients